Kilitch Drugs (India) MD, chairman and AGM

Kilitch Drugs (India) board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

Chairperson and managing directorMukund Prataprai Mehta
Managing directorMira Bhavin Mehta
Company Secretary and Compliance OfficerPushpa Nyoupane

6 directors3 independent3 executive

Mukund Prataprai Mehta · Chairperson and managing directorExecutive · joined May 1992 · reappointed Apr 2026 · 1 listed board
Bhavin Mukund MehtaExecutive · joined Sep 2007 · reappointed Sep 2022 · 1 listed board
Mira Bhavin Mehta · Managing directorExecutive · joined Sep 2014 · reappointed Nov 2023 · 1 listed board
Vasudev Krishna MurtiIndependent · joined Mar 2018 · reappointed Mar 2023 · 93 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
Venkita Subramanian RajanIndependent · joined Jun 2018 · reappointed Jun 2023 · 90 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
Dipen Jayantilal JainIndependent · joined Aug 2024 · reappointed Aug 2024 · 25 months as independent · 1 listed board · 1 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

Board
- 13 Aug 20264 of 6 present2 independent · 15 days in between
- 28 Jul 20265 of 6 present2 independent · 73 days in between
- 15 May 20265 of 6 present3 independent
Audit Committee
Chair Vasudev Krishna Murti
Dipen Jayantilal Jain, Venkita Subramanian Rajan
- 13 Aug 20262 of 3 present2 independent · 15 days in between
- 28 Jul 20262 of 3 present2 independent · 73 days in between
- 15 May 20263 of 3 present3 independent
Nomination and remuneration committee
Chair Dipen Jayantilal Jain
Vasudev Krishna Murti, Venkita Subramanian Rajan
- 28 Jul 20262 of 3 present2 independent
Stakeholders Relationship Committee
Chair Venkita Subramanian Rajan
Vasudev Krishna Murti, Dipen Jayantilal Jain
- 13 Aug 20262 of 3 present2 independent
Corporate Social Responsibility Committee
Chair Bhavin Mukund Mehta
Mira Bhavin Mehta, Vasudev Krishna Murti
- 28 Jul 20262 of 3 present0 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

M/s C Sharat and AssociatesPeer-review certificate valid to Dec 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Kilitch Drugs (India) AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Kilitch Drugs (India) dividend history

Annual general meeting, 27 Aug 2026

12,942 shareholders on the register on 20 Aug 2026; present: 3 promoters and 50 others; votes counted by Mr. Deep Shukla / Deep Shukla and Associates.The company's voting result (opens in a new tab)

To receive, consider, approve and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended 31st March, 2026, together with the Report of the Board of Directors and Auditors thereon;MoreLess
Ordinary
95.20% for4.80% against
Against: promoters 0.00% · institutions 0.00% · other public 47.52%
Turnout: all 70.95% · promoters 100.00% · institutions 3.37% · other public 19.95%
To re-appoint Mr. Mukund Mehta (DIN: 00147876) as a Director who retires by rotation and being eligible, offers himself for re-appointment
OrdinaryPromoters have an interest in it
95.20% for4.80% against
Against: promoters 0.00% · institutions 0.00% · other public 47.52%
Turnout: all 70.95% · promoters 100.00% · institutions 3.37% · other public 19.95%
To approve the payment of performance linked pay (PLI) to executive directors
Special
95.20% for4.80% against
Against: promoters 0.00% · institutions 0.00% · other public 47.52%
Turnout: all 70.95% · promoters 100.00% · institutions 3.37% · other public 19.95%
To ratify the remuneration to the Cost Auditor of the Company
Ordinary
95.20% for4.80% against
Against: promoters 0.00% · institutions 0.00% · other public 47.52%
Turnout: all 70.95% · promoters 100.00% · institutions 3.37% · other public 19.95%